Lost in Translation

Whitepaper | BioCentury

Lost in Translation

BioCentury is finding a fundamental disconnect in Europe. Pools of investment capital are forming around academic science, even as the money needed to get those discoveries into and through the clinic continues to lag. At the scene-setting Bio€quity Europe Face-Off, top Editors Susan Schaeffer of BioCentury and Simone Fishburn of BioCentury Innovations documented this conundrum and debated with the audience whether it could thwart European biotech's global ambitions.